1. Home
  2. SGRP vs LSTA Comparison

SGRP vs LSTA Comparison

Compare SGRP & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SPAR Group Inc.

SGRP

SPAR Group Inc.

HOLD

Current Price

$0.82

Market Cap

20.5M

ML Signal

HOLD

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$2.15

Market Cap

16.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGRP
LSTA
Founded
1967
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Misc Health and Biotechnology Services
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.5M
16.4M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
SGRP
LSTA
Price
$0.82
$2.15
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$23.50
AVG Volume (30 Days)
67.6K
40.9K
Earning Date
11-14-2025
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$147,130,000.00
$1,070,000.00
Revenue This Year
$7.22
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
21.79
N/A
52 Week Low
$0.76
$1.81
52 Week High
$2.10
$4.11

Technical Indicators

Market Signals
Indicator
SGRP
LSTA
Relative Strength Index (RSI) 43.18 56.25
Support Level $0.77 $1.84
Resistance Level $0.92 $2.27
Average True Range (ATR) 0.04 0.14
MACD 0.00 0.03
Stochastic Oscillator 41.92 72.41

Price Performance

Historical Comparison
SGRP
LSTA

About SGRP SPAR Group Inc.

SPAR Group Inc is a merchandising and brand marketing services company, providing a broad range of sales-enhancing services to retailers across classes of trade and consumer goods manufacturers and distributors. It also provides a range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from the Americas.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: